Ubs Group Ag Pasithea Therapeutics Corp. Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
Shares
7 transactions
About Pasithea Therapeutics Corp.
- Ticker KTTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,398,700
- Market Cap $75.8M
- Description
- Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 ...